Publications by authors named "Anna Beatriz Dos Santos Salgado"
Safety and Biodistribution of an Autologous Bone Marrow-Derived Mononuclear Cell Infusion into Renal Arteries in Patients with Focal Segmental Glomerulosclerosis: A Phase 1 Study.
Bruno Freire Botelho André Luis Barreira Marcio Gomes Filippo Karina Dutra Asensi Lanuza A P Faccioli Anna Beatriz Dos Santos Salgado
Stem Cells Int
July 2024
Article Synopsis
- The study investigated the safety of injecting bone marrow-derived mononuclear cells (BMDMCs) directly into the renal arteries of five patients with severe FSGS, using imaging to track where the cells went in the body.
- Results showed that the procedure was safe with no serious side effects, and there was a temporary increase in kidney markers, but overall kidney function remained stable during the follow-up period.
Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil.
Anna Beatriz Dos Santos Salgado Roberto Jose Pessoa Magalhães Robéria M Pontes Eduarda da Silva Barbosa Juan Flores-Montero
Cancers (Basel)
March 2023
Despite recent advances in multiple myeloma (MM), the incorporation of novel agents and measurable residual disease (MRD) monitoring in low-income countries remains a challenge. Although lenalidomide maintenance (M-Len) after autologous stem cell transplantation (ASCT) has been associated with improved outcomes and MRD has refined the prognosis of complete response (CR) cases, until now, there have been no data on the benefits of these approaches in Latin America. Here, we evaluate the benefits of M-Len and MRD using next-generation flow cytometry (NGF-MRD) at Day + 100 post-ASCT ( = 53).
View Article and Find Full Text PDF